KalVista Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Nicole Sweeny has spoken on 1 investor event across 1 company, most recently for KalVista Pharmaceuticals, Inc. on July 7, 2025. KalVista Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“I'm excited to talk about how we are working to put Ecterly into patients' hands as soon as possible. I want to reinforce a point that Ben shared earlier. Ecterly is based on a call to action for people living with HAE to act early when it comes to treating their attacks.”
KalVista Pharmaceuticals, Inc.
Proxy statement
Start not stated–present
Last confirmed August 21, 2025
KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
Ekterly FDA Approval Conference Call
KalVista Pharmaceuticals, Inc.
